Recombinant Canine IL-2

<strong>Recombinant Canine IL-2</strong>_x000D_ <strong>Catalog number:</strong> B2017850_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 µg_x000D_ <strong>Molecular Weight or Concentration:</strong> 15.6 kDa_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20¬∞C_x000D_ <strong>Keywords:</strong> Canine Interleukin 2, IL-2, T cell growth factor, TCGF, Aldesleukin_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MŒ©-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Pereira AM, de Pinheiro CG, Dos Santos LR, Teixeira NC, Chang YF, Pontes-de-Carvalho LC, de S√° Oliveira GG. Requirement of dual stimulation by homologous recombinant IL-2 and recombinant IL-12 for the in vitro production of interferon gamma by canine peripheral blood mononuclear cells BMC Res Notes. 2014 Jul 18;7:460._x000D_ 2: Li XZ, Lv L, Zhang X, Anchang KY, Abdullahi AY, Tu L, Wang X, Xia L, Zhang XX, Feng W, Lu C, Li S, Yuan ZG. Recombinant canine adenovirus type-2 expressing TgROP16 provides partial protection against acute Toxoplasma gondii infection in mice Infect Genet Evol. 2016 Nov;45:447-453._x000D_ 3: Asahina R, Nishida H, Kamishina H, Maeda S. Transcriptional analysis of the IL-33 receptor suppression of tumourigenicity 2 and its effects on canine Type 2 T helper cells: a preliminary study Vet Dermatol. 2018 Apr;29(2):112-e45._x000D_ 4: Liu Y, Sato H, Hamana M, Moonan NA, Yoneda M, Xia X, Kai C. Construction of an expression system for bioactive IL-18 and generation of recombinant canine distemper virus expressing IL-18 J Vet Med Sci. 2014 Sep;76(9):1241-8._x000D_ 5: Lee SH, Shin DJ, Kim SK. Generation of recombinant canine interleukin-15 and evaluation of its effects on the proliferation and function of canine NK cells Vet Immunol Immunopathol. 2015 May 15;165(1-2):1-13._x000D_ 6: Helfand SC, Modiano JF, Nowell PC. Immunophysiological studies of interleukin-2 and canine lymphocytes Vet Immunol Immunopathol. 1992 Jun;33(1-2):1-16._x000D_ 7: Li XZ, Wang XH, Xia LJ, Weng YB, Hernandez JA, Tu LQ, Li LT, Li SJ, Yuan ZG. Protective efficacy of recombinant canine adenovirus type-2 expressing TgROP18 (CAV-2-ROP18) against acute and chronic Toxoplasma gondii infection in mice BMC Infect Dis. 2015 Mar 4;15:114._x000D_ 8: Helfand SC, Soergel SA, Donner RL, Gan J, Hank JA, Lindstrom MJ, Sondel PM. Potential to involve multiple effector cells with human recombinant interleukin-2 and antiganglioside monoclonal antibodies in a canine malignant melanoma immunotherapy model J Immunother Emphasis Tumor Immunol. 1994 Oct;16(3):188-97._x000D_ 9: Somberg RL, Robinson JP, Felsburg PJ. Detection of canine interleukin-2 receptors by flow cytometry Vet Immunol Immunopathol. 1992 Jun;33(1-2):17-24._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/23383511">10: Chen H, Zhong F, Li X, Wang L, Sun Y, Neng C, Zhang K, Li W, Wen J. [Effects of canine IL-2 and IL-7 genes on enhancing immunogenicity of canine parvovirus VP2 gene vaccine in mice] Wei Sheng Wu Xue Bao. 2012 Nov 4;52(11):1392-9.</a>_x000D_ _x000D_ <strong>Products Related to Recombinant Canine IL-2 can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>